Logos Global Management LP 13D and 13G filings for NextCure, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 1:40 pm Sale |
2024-12-31 | 13G | NextCure, Inc. NXTC |
Logos Global Management LP | 0 0.000% |
-2,500,000![]() (Position Closed) |
Filing |
2024-11-14 6:59 pm Purchase |
2024-09-30 | 13G | NextCure, Inc. NXTC |
Logos Global Management LP | 2,500,000 8.900% |
499,540![]() (+24.97%) |
Filing |
2024-04-01 6:34 pm Purchase |
2024-04-01 | 13G | NextCure, Inc. NXTC |
Logos Global Management LP | 2,000,460 7.200% |
2,000,460![]() (New Position) |
Filing |